PDF: Prevention of Shingles in Dermatology Patients on Systemic Medications

PDF Download: Dermatologists should be proactive in recommending RZV to all patients over age 50 years, particularly those with a family history of zoster and diseases with altered immune function. Adult patients who are immunocompromised because of their diseases or treatment (e.g., systemic steroids, JAK inhibitors, combination biologic/conventional disease-modifying antirheumatics), should also be encouraged.
Read online:
Prevention of Shingles in Dermatology Patients on Systemic Medications